good and everyone. Mike, morning, Thanks,
reported extraordinary in solid quarter every As morning's team very thousands single focused the Despite fourth on in the we'll fronts Health results patients ongoing on the delivering discuss was another this quarter. Care rely the that release, we on us this on delivered of care many team morning's to call, press challenges of relentlessly Option who day.
over and the dedication And setting. by to reflecting made on year in team or unsurpassed outcomes providing superior last the of the honored transform clinical in am a and the help whole, by XXXX care our we've the ambulatory as to humbled health by progress care home I mission advance
unique offer biopharma period, the care cost. at over most highest care XXX,XXX relationships During patients time with XXXX, our quality and to their we payers, the provided family. over this providers And to appropriate and we continue to expand
our acute As growth results. grew of therapies growth in both Mike with coming and mid-single we over growth. digits balanced XX%, more the granular of double-digit in But the provide overview generated from will a therapy always, QX, revenue that chronic
EBITDA X.X% steal margin of despite balance has X.X%, to adjusted adjusted quarter, generated the pressures. we never my time, but And growth same inflationary third importantly, delivered our an thunder, continued points not sheet and the of XX from up been basis sequentially stronger. At EBITDA
finished we with cash, the and net times. in year year ended our at As the million $XXX leverage X.X
anyone on, Entering in the year, anticipated previously, than and endure across the our that year-over-year $XX supplies, more that the inputs. cost Throughout broader and oil-derived pressures felt of we in XXXX, significant the operating inputs. we don't we I emerging economy as pressures inflationary head believe many conservatively we have impact or would cost million digested pressures faced labor, medical products communicated
pressures those collaborated as operating our seek to partners offsetting also on rate to reasonable and possible payer technology we the through enhancements efficiencies driving best where focused We extent increases with appropriate.
Our forward. never pursuit drove the of and new leverage basis the is ends, we considerable what going cost operating believe team efficiencies in
also a labor We to market. difficult manage continue very through
what we pharmacy Nursing combined established the largest network in is platform, network believe our with specialty April, of Infinity acquisition we nursing Infusion the With the network infusion nursing clinical have last country.
we as to key our many, and allowing clinical with recruiting than to sources adequate and confident can better us staffing we while the weathering choice them And their storm our maintain disciplines dependable partner we we capacity, a provide remains challenging, serve are clinical reputation continue employer to are referral patients. an as of
nearly total year, count infusion centers, also and over to increasing infusion opened increases which new total our During the XX to chairs, added sites XXX XX ambulatory our we XXX.
of visits XX%. percentage suites, continue see now capitalizing greater and in footprint our patient With approaching we on to the preference, infusion our nursing expanded
will This greater over XX expansion high will our operating open and in patient satisfaction with efficiencies XXXX We key plans scores. markets. sites for to allow continue in continued additional
the productive exceeding In in adjusted very was delivered year delivering EBITDA. $XXX.X for EBITDA adjusted XXXX million million to a our we year, $XXX original in million full as $XXX summary, guidance of
As confident leverage to execution ability remain strong in ahead our operations digit top through flow growth to mid high-single line to XXXX, bottom look partnerships. we from cash I line, deepening and and strong deliver
We stakeholders emerge. models meaningful marketplace solutions to will key continue and the focus our on new to providing as evolves
value-based consistent, arrangements We care will the to cost and payers closely appropriate members the with work infusion an services country. requiring high-quality across for offer continue to their at explore
with their broadly prescribers will collaborate service provide and care planners with members patients their We to us discharge team. partner of extended as of and on to seamless transition
patients will We them an as our so help conditions to they acute manage the live chronic event their unsurpassed support them provide from can or deepen to fuller. our relationships they life with recover
of analytics the patients platform we And And our data clinical will medicines. trials clinical to their people that provide support invest destination will receiving to employer will in for to are new as provide and in the and remain broadest passionate we for conduct development professionals. therapies population training access choice they and care pharma provide strongest or an and we for strengthen that we the novel advancement as capture continue opportunities health of
$XXX and discipline profile. August have highlight to XXXX far our have the we strengthen strategy. repurchase acknowledge as in capital Directors to in of flow, part of announced our since in authorization more Also to how this the allocation improve however, color proof unlock as release, of from and provide received morning's balance we will free this merger million cash I we wanted on have multifaceted shares program, this applied Mike a come that Board leverage of we positive sheet vastly our
results call further. turn to Mike to with Mike? the the review And over I'll that,
